Brief: Athenex Announces Phased European Launch Of Klisyri For Treatment Of Actinic Keratosis

Athenex

27/09/2021 13:23

Sept 27 (Reuters) - Almirall SA  ALM.MC :
    * ATHENEX ANNOUNCES PHASED EUROPEAN LAUNCH OF KLISYRI®
(TIRBANIBULIN) FOR THE TREATMENT OF ACTINIC KERATOSIS
    * ATHENEX INC -  PARTNER, ALMIRALL HAS LAUNCHED KLISYRI IN
GERMANY
AND UK
    * ATHENEX INC - ELIGIBLE TO RECEIVE UP TO $45 MILLION IN
MILESTONE
PAYMENTS ASSOCIATED WITH LAUNCH AND EXPANSION INTO ADDITIONAL
INDICATIONS

Source text for Eikon:  ID:nGNX2tPF1Q 
Further company coverage:  ALM.MC 

 ((Reuters.Briefs@thomsonreuters.com;))